Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer

NCT04358354 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

388

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Gastric Cancer

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: 5-fluorouracil

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University